Gudmar Lönnerholm
Affilierad Professor emeritus vid Institutionen för kvinnors och barns hälsa; Barnonkologisk forskning - särskilt fokus på komplikationer
- Telefon:
- 018-611 58 96
- Fax:
- 018-611 58 53
- E-post:
- gudmar.lonnerholm@uu.se
- Besöksadress:
- MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala - Postadress:
- Akademiska sjukhuset
751 85 UPPSALA
- Akademiska meriter:
- MD, överläk.
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling (2024)
- Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia (2023)
- Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia (2023)
- RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children (2021)
- Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia (2021)
Alla publikationer
Artiklar
- Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling (2024)
- Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia (2023)
- Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia (2023)
- RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children (2021)
- Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia (2021)
- The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome (2020)
- Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia (2020)
- Refined detection and phasing of structural aberrations in pediatric acute lymphoblastic leukemia by linked-read whole-genome sequencing (2020)
- CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia (2019)
- DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia (2018)
- CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia (2017)
- Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles (2017)
- Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes (2016)
- PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia (2016)
- CopyNumber450kCancer (2016)
- DNA methylome analysis of acute lymphoblastic leukemia cells reveals stochastic de novo DNA methylation in CpG islands (2016)
- The Mutational Landscape in Pediatric Acute Lymphoblastic Leukemia Deciphered by Whole Genome Sequencing (2015)
- DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia (2015)
- Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment (2013)
- Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia (2013)
- The DNA Methylation Landscape of Paediatric Acute Lymphoblastic Leukemia (2012)
- Digital gene expression profiling of primary acute lymphoblastic leukemia cells (2012)
- DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at Remission (2012)
- Response: High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia (2012)
- In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia (2011)
- Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia (2011)
- Minimal residual disease assessment in childhood acute lymphoblastic leukaemia (2011)
- The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia (2011)
- DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia (2010)
- Vincristine pharmacokinetics in children with Down syndrome (2009)
- Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids (2009)
- In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia (2009)
- Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia (2009)
- Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation (2009)
- Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia (2009)
- Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia (2009)
- Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia (2008)
- Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome (2008)
- Dendritic cell regeneration in the bone marrow of children treated for acute lymphoblastic leukaemia (2007)
- Etoposide pharmacokinetics in children treated for acute myeloid leukemia (2006)
- High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. (2006)
- Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia (2005)
- Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. (2005)
- Growth post transplant. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia (2004)
- Pulmonary function after autologous bone marrow transplantation in children (2004)
- Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. (2004)
- Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia (2003)
- Pharmacokinetics of Doxorubicin in Children with Acute Lymphoblastic Leukemia (2002)
- In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia (2002)
- Cataracts after autologous bone marrow transplantation in children (2000)
- Identification of somatic single nucleotide variants inleukemia by targeted sequencing of non-indexed overlapping pools
- DNA methylation classification in combination with RNA-sequencing for subtype discovery in pediatric B-cell precursor acute lymphoblastic leukemia
- Refined detection and phasing of structural aberrations in pediatric acute lymphoblastic leukemia with linked-read whole genome sequencing